Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

LANABIOTIC

BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Standard Dose
400 UNITS/GM;40MG/GM;EQ 5MG BASE/GM;5,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview LANABIOTIC is listed in Drugs@FDA under application 062499 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;TOPICAL - 400 UNITS/GM;40MG/GM;EQ 5MG BASE/GM;5,000 UNITS/GM Sponsor COMBE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview LANABIOTIC is listed in Drugs@FDA under application 062499 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;TOPICAL - 400 UNITS/GM;40MG/GM;EQ 5MG BASE/GM;5,000 UNITS/GM Sponsor COMBE Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.